You are here

Article info

Article menu
XML
Diabetes and endocrinology
Research
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes

Authors

  1. Correspondence to Professor Norman Waugh; Norman.Waugh{at}warwick.ac.uk
View Full Text

Citation

Clar C, Gill JA, Court R, et al
Systematic review of SGLT2 receptor inhibitors in dual or triple therapy in type 2 diabetes
BMJ Open 2012;2:e001007. doi: 10.1136/bmjopen-2012-001007

Publication history

  • Received February 15, 2012
  • Accepted August 24, 2012
  • First published October 18, 2012.
Online issue publication 
October 26, 2017
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.